DOPAMINE BETA HYDROXYLASE

  1. Serum DOPAMINEBETAHYDROXYLASE activity
  2. DOPAMINE BETAHYDROXYLASE deficiency. A genetic disorder of cardiovascular regulation.
  3. DOPAMINE BETAHYDROXYLASE of adrenal chromaffin granules: structure and function
  4. DOPAMINE BETAHYDROXYLASE deficiency
  5. Reduced DOPAMINEBETAHYDROXYLASE activity in Alzheimer’s disease
  6. DOPAMINE BETAHYDROXYLASE : biochemistry and molecular biology.
  7. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine HYDROXYLASE and DOPAMINEBETAHYDROXYLASE
  8. DOPAMINEBETAHYDROXYLASE
  9. DOPAMINE BETAHYDROXYLASE and its genetic variants in human health and disease
  10. Association of the DOPAMINE BETA HYDROXYLASE gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study
  11. Localization of the human DOPAMINE BETA HYDROXYLASE (DBH) gene to chromosome 9q34
  12. Endogenous restoration of noradrenaline by precursor therapy in DOPAMINEBETAHYDROXYLASE deficiency
  13. Clinical presentation and long‐term follow‐up of DOPAMINE BETA HYDROXYLASE deficiency
  14. Congenital DOPAMINEBETAHYDROXYLASE deficiency: A novel orthostatic syndrome
  15. The primary structure of human DOPAMINEBETAHYDROXYLASE : insights into the relationship between the soluble and the membrane‐bound forms of the enzyme.
  16. Kinetic and spectroscopic studies of the interaction of copper with DOPAMINE BETAHYDROXYLASE .
  17. Tyrosine HYDROXYLASE , but not DOPAMINE BETAHYDROXYLASE , is increased in rat frontal cortex after traumatic brain injury
  18. A genetic association study of migraine with DOPAMINE receptor 4, DOPAMINE transporter and DOPAMINEBETAHYDROXYLASE genes
  19. Inheritance of very low serum DOPAMINEBETAHYDROXYLASE activity.
  20. DOPAMINE BETAHYDROXYLASE gene modulates individuals’ empathic ability
  21. Plasma DOPAMINE BETAHYDROXYLASE activity in psychotic and non-psychotic post-traumatic stress disorder
  22. Mechanism-based inactivation of DOPAMINE. BETA.-HYDROXYLASE by p-cresol and related alkylphenols
  23. Attention deficit hyperactivity disorder and the gene for DOPAMINE BETAHYDROXYLASE
  24. Regulation of DOPAMINE BETAHYDROXYLASE in rat adrenal glands.
  25. Association between a 19 bp deletion polymorphism at the DOPAMINE BETAHYDROXYLASE (DBH) locus and migraine with aura
  26. Neuron-specific expression of the human DOPAMINE BETAHYDROXYLASE gene requires both the cAMP-response element and a silencer region.
  27. Effects of reserpine on activities and amounts of tyrosine HYDROXYLASE and DOPAMINEBETAHYDROXYLASE in catecholamine neuronal systems in rat brain.
  28. Multisubstrate inhibitors of DOPAMINE. BETA.-HYDROXYLASE . 2. Structure-activity relationships at the phenethylamine binding site
  29. DOPAMINE BETAHYDROXYLASE (DBH) activity and ‐1021C/T polymorphism of DBH gene in combat‐related post‐traumatic stress disorder
  30. Linkage of a gene regulating DOPAMINEBETAHYDROXYLASE activity and the ABO blood group locus.
  31. Ultrastructural demonstration of noradrenergic synapses in the rat central nervous system by DOPAMINEBETAHYDROXYLASE immunocytochemistry.
  32. Effects of acupuncture on serum cortisol level and DOPAMINE BETAHYDROXYLASE activity in normal Chinese
  33. Characterization of a carbon monoxide complex of reduced DOPAMINE BETAHYDROXYLASE . Evidence for inequivalence of the Cu (I) centers.
  34. Genotype-independent decrease in plasma DOPAMINE BETAHYDROXYLASE activity in Alzheimer’s disease
  35. Human DOPAMINE BETAHYDROXYLASE (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure
  36. The DOPAMINE BETAHYDROXYLASE inhibitor nepicastat increases DOPAMINE release and potentiates psychostimulant‐induced DOPAMINE release in the prefrontal cortex
  37. Isolation and reconstitution of the membrane-bound form of DOPAMINE BETAHYDROXYLASE .
  38. … neuronal perikarya and fibres in the brain of a teleost, Gasterosteus aculeatus L. comparison with tyrosine HYDROXYLASE -and DOPAMINEBETAHYDROXYLASE
  39. Functional and high level expression of human DOPAMINE BETAHYDROXYLASE in transgenic mice.
  40. In vivo cell type-specific CRISPR knockdown of DOPAMINE BETA HYDROXYLASE reduces locus coeruleus evoked wakefulness
  41. DOPAMINEBETAHYDROXYLASE in the cerebrospinal fluid of psychiatric patients.
  42. Soluble and membrane-bound forms of DOPAMINE BETAHYDROXYLASE are encoded by the same mRNA.
  43. Functional model of DOPAMINE. BETA.-HYDROXYLASE . quantitative ligand hydroxylation at the benzylic position of a copper complex by dioxygen
  44. DOPAMINE BETA HYDROXYLASE genotype identifies individuals less susceptible to bias in computer-assisted decision making
  45. Polymorphisms and low plasma activity of DOPAMINEBETAHYDROXYLASE in ADHD children
  46. Low DOPAMINEBETAHYDROXYLASE : a biological sequela of abuse and neglect?
  47. Development of DOPAMINEBETA HYDROXYLASE —positive fiber innervation of the rat hippocampus
  48. Carbonmonoxy DOPAMINE BETAHYDROXYLASE . Structural characterization by Fourier transform infrared, fluorescence, and x-ray absorption spectroscopy.
  49. DOPAMINE BETAHYDROXYLASE (DBH) gene and schizophrenia phenotypic variability: A genetic association study
  50. Selective depletion of cortical noradrenaline by anti-DOPAMINE BETAHYDROXYLASE –saporin impairs attentional function and enhances the effects of guanfacine in the rat
  51. The expression of dopa decarboxylase and DOPAMINE BETA HYDROXYLASE and their responding to bacterial challenge during the ontogenesis of scallop Chlamys farreri
  52. DOPAMINE BETAHYDROXYLASE participate in the immunoendocrine responses of hypothermal stressed white shrimp, Litopenaeus vannamei
  53. Regional brain abnormalities in norepinephrine uptake and DOPAMINE BETAHYDROXYLASE activity in the genetically epilepsy-prone rat.
  54. Positive association between− 1021TT genotype of DOPAMINE BETA HYDROXYLASE gene and progressive behavior of injection heroin users
  55. Design and kinetic characterization of multisubstrate inhibitors of DOPAMINE. BETA.-HYDROXYLASE
  56. Decreased DOPAMINE BETAHYDROXYLASE activity in unipolar geriatric delusional depression
  57. DOPAMINEBETAHYDROXYLASE (DBH) and homovanillic acid (HVA) in autistic children
  58. Cell-specific expression from the human DOPAMINE BETAHYDROXYLASE promoter in transgenic mice is controlled via a combination of positive and negative regulatory …
  59. … postural hypotension and sympathetic failure due to an inability to synthesize noradrenaline from DOPAMINE because of a deficiency of DOPAMINE BETA HYDROXYLASE
  60. Analysis of DOPAMINE BETA HYDROXYLASE gene polymorphisms in migraine
  61. Association of DOPAMINE BETAHYDROXYLASE polymorphisms with alzheimer’s disease, Parkinson’s disease and schizophrenia: evidence based on currently available …
  62. Copper K-extended x-ray absorption fine structure studies of oxidized and reduced DOPAMINE BETAHYDROXYLASE . Confirmation of a sulfur ligand to copper (I) in …
  63. Electron spin-echo studies of the copper (II) binding sites in DOPAMINE. BETA.-HYDROXYLASE
  64. Minor physical anomalies and plasma DOPAMINEBETAHYDROXYLASE activity in hyperactive boys
  65. DOPAMINE. BETA.-HYDROXYLASE : activity and inhibition in the presence of. BETA.-substituted phenethylamines
  66. Serum DOPAMINEBETAHYDROXYLASE during development of immobilization—induced hypertension
  67. … mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following DOPAMINEBETAHYDROXYLASE inhibition.
  68. Cardiovascular effects of a new potent DOPAMINE BETAHYDROXYLASE inhibitor in spontaneously hypertensive rats.
  69. DOPAMINEBETA HYDROXYLASE polymorphism and cocaine addiction
  70. Selective inhibition of DOPAMINEBETAHYDROXYLASE enhances DOPAMINE release from noradrenergic terminals in the medial prefrontal cortex
  71. Association between DOPAMINE BETA HYDROXYLASE rs5320 polymorphism and smoking behaviour in elderly Japanese
  72. Plasma noradrenaline and DOPAMINEBETAHYDROXYLASE during human sexual activity
  73. The copper sites of DOPAMINE. BETA.-HYDROXYLASE : an x-ray absorption spectroscopic study
  74. Release of catecholamines and DOPAMINE BETAHYDROXYLASE from the perfused adrenal gland of the cat.
  75. Inactivation of DOPAMINE. BETA.-HYDROXYLASE by p-cresol: isolation and characterization of covalently modified active site peptides
  76. Human plasma DOPAMINE BETAHYDROXYLASE . Purification and properties.
  77. Involvement of DOPAMINE BETAHYDROXYLASE in the neuroendocrine-immune regulatory network of white shrimp, Litopenaeus vannamei
  78. The mechanism of inactivation of DOPAMINE BETAHYDROXYLASE by hydrazines.
  79. Suppression of ethanol intake following administration of DOPAMINEBETAHYDROXYLASE inhibitors in rats.
  80. Antihypertensive effect of a DOPAMINE BETA HYDROXYLASE inhibitor, bupicomide: a comparison with hydralazine
  81. Plasma norepinephrine concentration and plasma DOPAMINEBETAHYDROXYLASE activity in patients with congestive heart failure.
  82. Multisubstrate inhibitors of DOPAMINE. BETA.-HYDROXYLASE . 1. Some 1-phenyl and 1-phenyl-bridged derivatives of imidazole-2-thione
  83. Plasma adrenaline and noradrenaline concentrations and DOPAMINEBETAHYDROXYLASE activity in myocardial infarction with and without cardiogenic shock.
  84. … catecholaminergic modulation of visual attention: differential effects of catechol-O-methyltransferase and DOPAMINE BETAHYDROXYLASE genes on visual …
  85. Analysis of the DOPAMINE BETA HYDROXYLASE gene in Gilles de la Tourette syndrome
  86. Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in DOPAMINE BETA HYDROXYLASE knockout mice
  87. Reflex control of sympathetic nerve activity in DOPAMINE BETAHYDROXYLASE deficiency.
  88. DOPAMINE BETAHYDROXYLASE activity in cerebrospinal fluid of parkinsonian patients
  89. Mechanism of biosynthesis of soluble and membrane-bound forms of DOPAMINE BETAHYDROXYLASE in PC12 pheochromocytoma cells.
  90. Bovine DOPAMINE BETAHYDROXYLASE cDNA. Complete coding sequence and expression in mammalian cells with vaccinia virus vector.
  91. Changes of DOPAMINEBETAHYDROXYLASE activity during ontogenesis in healthy subjects and in an experimental model (rats)
  92. Human pheochromocytoma DOPAMINEBETAHYDROXYLASE : purification and molecular parameters of the tetramer
  93. Asymmetric sulfoxidation by DOPAMINE. BETA.-HYDROXYLASE , an oxygenase heretofore considered specific for methylene hydroxylation
  94. The cAMP-dependent protein kinase regulates transcription of the DOPAMINE BETAHYDROXYLASE gene
  95. … noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and DOPAMINEBETAHYDROXYLASE
  96. … : linkage analysis excludes a role for the genes coding for DOPAMINE D1, D2, D3, D4, D5 receptors, DOPAMINE BETA HYDROXYLASE , tyrosinase, and tyrosine HYDROXYLASE
  97. Preparation and Characterization of Half-Apo DOPAMINE-. BETA.-HYDROXYLASE by Selective Removal of CuA. Identification of a Sulfur Ligand at the Dioxygen Binding …
  98. Serum DOPAMINEBETAHYDROXYLASE activity: Clinical applications in child psychiatry
  99. Human serum DOPAMINE BETAHYDROXYLASE : correlation of enzymatic activity with immunoreactive protein in genetically defined samples.
  100. Deduction of kinetic mechanism in multisubstrate enzyme reactions from tritium isotope effects. Application to DOPAMINE BETAHYDROXYLASE .
  101. Subunit exchange between membranous and soluble forms of bovine DOPAMINE BETAHYDROXYLASE .
  102. Impaired temporal resolution of visual attention and DOPAMINE BETA HYDROXYLASE genotype in attention-deficit/hyperactivity disorder
  103. Association between DOPAMINE BETA HYDROXYLASE gene and attention deficit hyperactivity disorder complicated with disruptive behavior disorder
  104. Mechanism-based inhibitors of DOPAMINE. BETA.-HYDROXYLASE containing acetylenic or cyclopropyl groups
  105. Measurement of human DOPAMINEBETAHYDROXYLASE in serum by homologous radioimmunoassay.
  106. Alternate substrates of DOPAMINE BETAHYDROXYLASE . I. Kinetic investigations of benzyl cyanides as substrates and inhibitors.
  107. Serum DOPAMINEBETAHYDROXYLASE in affective disorders
  108. DOPAMINE BETA HYDROXYLASE (DBH) plasma activity in childhood mental disorders
  109. Antihypertensive activities of phenyl aminoethyl sulfides, a class of synthetic substrates for DOPAMINE. BETA.-HYDROXYLASE
  110. Increased ganglionic tyrosine HYDROXYLASE and DOPAMINEBETAHYDROXYLASE activities following preganglionic nerve stimulation: role of nicotine receptors.
  111. The pH-dependent subunit dissociation and catalytic activity of bovine DOPAMINE BETAHYDROXYLASE .
  112. The role of norepinephrine in the function of the area postrema. I. Immunofluorescent localization of DOPAMINEBETAHYDROXYLASE and electron microscopy
  113. Partial characterization of a naturally occurring inhibitor of DOPAMINE BETAHYDROXYLASE .
  114. Decreased serum DOPAMINEBETAHYDROXYLASE in hyperthyroidism
  115. The activity of DOPAMINEBETAHYDROXYLASE and methionine-activating enzyme in blood of schizophrenic patients.
  116. … -substituted imidazoles, triazoles, tetrazoles, pyridinethiones, and structural relatives as multisubstrate inhibitors of DOPAMINE. BETA.-HYDROXYLASE . 4. Structure-activity …
  117. Linkage disequilibrium analysis of the DOPAMINE BETAHYDROXYLASE gene in persistent attention deficit hyperactivity disorder
  118. Unsaturated heterocyclic amines as potent time-dependent inhibitors of DOPAMINE. BETA.-HYDROXYLASE
  119. Analysis of polymorphisms in the DOPAMINE BETA HYDROXYLASE gene: association with attention deficit hyperactivity disorder in Indian children
  120. Platelet monoamine oxidase, plasma DOPAMINEBETAHYDROXYLASE and attention in a” biochemical high risk” sample.
  121. Sleep patterns in congenital DOPAMINE BETAHYDROXYLASE deficiency
  122. Effects of disulfiram and DOPAMINE BETAHYDROXYLASE knockout on cocaine-induced seizures
  123. Complete Assignment of Disulfide Bonds in Bovine DOPAMINE. BETA.-HYDROXYLASE
  124. 3-Phenylpropenes as mechanism-based inhibitors of DOPAMINE. BETA.-HYDROXYLASE : evidence for a radical mechanism
  125. ABO B gene is associated with introversion personality tendancies through linkage with DOPAMINE BETA HYDROXYLASE gene
  126. DOPAMINEBETAHYDROXYLASE in behaviorally disturbed youth: Relationship between teacher and parent ratings
  127. Release of norepinephrine and DOPAMINEBETAHYDROXYLASE by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.
  128. Purified cytochrome b561 catalyzes transmembrane electron transfer for DOPAMINE BETAHYDROXYLASE and peptidyl glycine alpha-amidating monooxygenase …
  129. Lack of significant association between− 1021C→ T polymorphism in the DOPAMINE BETA HYDROXYLASE gene and attention deficit hyperactivity disorder
  130. Plasma DOPAMINE BETAHYDROXYLASE : rapid diagnostic test for recurrent hereditary polyserositis
  131. The distribution of DOPAMINEBETAHYDROXYLASE , neuropeptide Y and galanin in locus coeruleus neurons.
  132. Identification and functional characterisation of a novel DOPAMINE BETA HYDROXYLASE gene variant associated with attention deficit hyperactivity disorder
  133. A DOPAMINE BETA HYDROXYLASE from Chlamys farreri and its induced mRNA expression in the haemocytes after LPS stimulation
  134. Changes in plasma catecholamines and DOPAMINE BETAHYDROXYLASE after corrective surgery for coarctation of the aorta.
  135. . BETA.-Substituted phenethylamines as high-affinity mechanism-based inhibitors of DOPAMINE. BETA.-HYDROXYLASE
  136. Can DOPAMINE BETAHYDROXYLASE Levels Predict Adverse Reactions to Disulfiram?
  137. DOPAMINEBETAHYDROXYLASE activity and catecholamine levels in the plasma of patients with renal failure
  138. Plasma norepinephrine, epinephrine, and DOPAMINE BETAHYDROXYLASE activity during exercise in man.
  139. Primary amino acid sequence of bovine DOPAMINE BETAHYDROXYLASE .
  140. Association between DOPAMINE BETAHYDROXYLASE 19-bp insertion/deletion polymorphism and major depressive disorder
  141. A bifunctional genetic regulatory element of the rat DOPAMINE BETAHYDROXYLASE gene influences cell type specificity and second messenger-mediated …
  142. Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in DOPAMINEBETAHYDROXYLASE deficiency
  143. … to the anxiety-modulating effects of offspring contact is associated with innate anxiety and brainstem levels of DOPAMINE BETAHYDROXYLASE in female laboratory rats
  144. Determination of serum DOPAMINE-. BETA.-HYDROXYLASE activity by reverse-phase liquid chromatography with column switching
  145. The meaning of DOPAMINE BETAHYDROXYLASE in essential hypertension.
  146. Elevated plasma DOPAMINE BETA HYDROXYLASE activity in rats with neurogenic hypertension
  147. Exocytotic release of catecholamines and DOPAMINEBETAHYDROXYLASE from the perfused adrenal gland of the rabbit and cat.
  148. DOPAMINE BETAHYDROXYLASE inhibition in a patient with Wilson’s disease and manic symptoms.
  149. The effect of some dithiocarbamic acids on DOPAMINEBETAHYDROXYLASE and catecholamines level in rat’s brain.
  150. Effect of acute volume alterations on norepinephrine and DOPAMINEBETAHYDROXYLASE in normotensive and hypertensive subjects.
  151. DOPAMINEBETAHYDROXYLASE : an index of adrenergic function in hypertensive patients
  152. Association of DOPAMINE BETAHYDROXYLASE polymorphism with attention deficit hyperactivity disorder in children
  153. Maternal and fetal plasma renin and DOPAMINEBETAHYDROXYLASE activities in toxemic pregnancy.
  154. Nerve stimulation-meditated overflow of norepinephrine and DOPAMINEBETAHYDROXYLASE . III. Effects of norepinephrine depletion on the alpha presynaptic regulation …
  155. Association of a DOPAMINE BETAHYDROXYLASE gene variant with depression in elderly women possibly reflecting noradrenergic dysfunction
  156. Inhibition of DOPAMINE. BETA.-HYDROXYLASE by 5-phenoxymethyl-2-oxazolidinethiones
  157. Localization of DOPAMINEBETAHYDROXYLASE -like immunoreactivity in the superior olivary complex of the rat.
  158. DOPAMINEBETAHYDROXYLASE 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine
  159. An acetylenic mechanism-based inhibitor of DOPAMINE BETAHYDROXYLASE .
  160. Plasma noradrenaline and DOPAMINEBETAHYDROXYLASE during sexual activity
  161. Mosaic deletion 11p13 in a child with DOPAMINE BETAHYDROXYLASE deficiency—Case report and review of the literature
  162. … reinforcing properties of ethanol: II. Extinction of ethanol-drinking behavior in laboratory rats by inhibition of DOPAMINEBETAHYDROXYLASE . Implications for treatment …
  163. Active site of DOPAMINE. BETA.-HYDROXYLASE . Comparison of enzyme derivatives containing four and eight copper atoms per tetramer using potentiometry and EPR …
  164. Noradrenergic innervation of the human adrenal cortex as revealed by DOPAMINEBETAHYDROXYLASE immunohistochemistry.
  165. A Preliminary Study of DBH (Encoding DOPAMINE BETAHYDROXYLASE ) Genetic Variation and Neural Correlates of Emotional and Motivational …
  166. DOPAMINE BETAHYDROXYLASE . Inactivation by a suicide substrate.
  167. … in relation to variation in three genes involved in DOPAMINE metabolism: Catechol-O-methyltransferase (COMT), DOPAMINE BETAHYDROXYLASE (DBH) and monoamine …
  168. Plasma DOPAMINEBETAHYDROXYLASE activity in oral contraceptive hypertension.
  169. Serum DOPAMINEBETAHYDROXYLASE activity in acute stroke.
  170. Lack of correlation of plasma norepinephrine and DOPAMINEBETAHYDROXYLASE in hypertensive and normotensive subjects.
  171. Inhibitors of DOPAMINE. BETA.-HYDROXYLASE . 3. Some 1-(pyridylmethyl) imidazole-2-thiones
  172. Anti-DOPAMINE BETAHYDROXYLASE immunotoxin-induced sympathectomy in adult rats.
  173. CONCOMITANT ELEVATION OF TYROSINE HYDROXYLASE AND DOPAMINE BETAHYDROXYLASE BY CYCLIC AMP IN CULTURED MOUSE …
  174. Segregation and linkage studies of plasma DOPAMINEBETAHYDROXYLASE (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase …
  175. Sulfation and constitutive secretion of DOPAMINE BETAHYDROXYLASE from rat pheochromocytoma (PC12) cells.
  176. Serum DOPAMINE BETAHYDROXYLASE activity in menstrual migraine.
  177. Suppression of voluntary ingestion of morphine by inhibition of DOPAMINEBETAHYDROXYLASE .
  178. Genes for catecholamine biosynthesis: cloning by expression and identification of the cDNA for rat DOPAMINE BETAHYDROXYLASE .
  179. The sympathetic skin response in peripheral autonomic failure—evaluation in pure autonomic failure, pure cholinergic dysautonomia and DOPAMINEBETAHYDROXYLASE
  180. ABO group B is associated with personality traits through linkage disequilibrium with low activity DOPAMINE BETA HYDROXYLASE
  181. DOPAMINE BETAHYDROXYLASE and its role in regulating the growth and larval metamorphosis in Sinonovacula constricta
  182. The DOPAMINE BETAHYDROXYLASE gene polymorphism rs1611114 is associated with schizophrenia in the Chinese Zhuang but not Chinese Han population
  183. Pharmacological action of FD-008, a new DOPAMINE BETAHYDROXYLASE inhibitor. I. Effects on blood pressure in rats and dogs.
  184. Effect of Hypophysectomy on Serum DOPAMINEBETAHYDROXYLASE Activity in Rat
  185. Kinetic characterization of rat serum DOPAMINEBETAHYDROXYLASE using a simplified radioenzymatic assay
  186. Family studies of plasma DOPAMINEBETAHYDROXYLASE thermal stability.
  187. Isomer specific kinetics of DOPAMINE BETAHYDROXYLASE and arylsulfatase towards catecholamine sulfates.
  188. In vivo biosynthesis of two subunit forms of DOPAMINE BETAHYDROXYLASE in rat brain
  189. Expression of DOPAMINE BETAHYDROXYLASE in Drosophila Schneider 2 cells. Evidence for a mechanism of membrane binding other than uncleaved signal peptide
  190. PLASMA DOPAMINEBETAHYDROXYLASE ACTIVITY IN PHAEOCHROMOCYTOMA
  191. Genetic analysis of serum DOPAMINEBETAHYDROXYLASE activity in rats
  192. Tissue and plasma catecholamines and DOPAMINE BETAHYDROXYLASE activity of various animal species after neurogenic sympathetic stimulation.
  193. Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of DOPAMINE. BETA.-HYDROXYLASE
  194. Bovine DOPAMINE. BETA.-HYDROXYLASE , primary structure determined by cDNA cloning and amino acid sequencing
  195. Isotope effects in the hydroxylation of phenylethylamine by DOPAMINE. BETA.-HYDROXYLASE
  196. Effect of an inhibitor of DOPAMINEBETAHYDROXYLASE on the acquisition and retention of four different avoidance tasks in mice
  197. Distribution of DOPAMINEBETAHYDROXYLASE -like immunoreactive fibers in the rat cerebellar cortex during ontogeny
  198. On-line synthesis utilizing immobilized enzyme reactors based upon immobilized DOPAMINE BETAHYDROXYLASE
  199. Serum DOPAMINEBETAHYDROXYLASE activity and blood pressure.
  200. Plasma DOPAMINEBETAHYDROXYLASE in depressed patients and controls
  201. Clonidine reverses the amnesia induced by DOPAMINE BETA HYDROXYLASE inhibition
  202. Possible increase of DOPAMINEBETAHYDROXYLASE activity in the locus ceruleus of paranoid schizophrenic patients: a preliminary post-mortem study
  203. Effect of BETA-adrenergic blockade on circulating catecholamines and DOPAMINEBETAHYDROXYLASE activity during exercise in normal subjects
  204. 24-hour DOPAMINEBETAHYDROXYLASE pattern: A possible biological index of manic-depression
  205. DOPAMINE BETA HYDROXYLASE gene polymorphism and Parkinson’s disease
  206. Regulation of the multiple forms of DOPAMINE BETAHYDROXYLASE by nerve growth factor, dexamethasone, and dibutyryl cyclic AMP in the PC12 pheochromocytoma cell …
  207. DOPAMINEBETAHYDROXYLASE -positive nerves in normal and transplanted pancreatic tissue in the anterior eye-chamber of rats
  208. Neuropeptide Y plasma levels and serum DOPAMINEBETAHYDROXYLASE activity in MS patients with and without abnormal cardiovascular reflexes.
  209. A genetic study of plasma DOPAMINE BETA HYDROXYLASE activity in man
  210. The effects of ganglionic blockade, reserpine and vinblastine on plasma catecholamines and DOPAMINEBETAHYDROXYLASE in the rat.
  211. Plasma DOPAMINEBETAHYDROXYLASE in identical twins discordant for schizophrenia
  212. … characterization of bipolar affective disorders: a focus on tardive dyskinesia and soft neurological signs in relation to serum DOPAMINE BETA HYDROXYLASE activity
  213. Activity of the enzymes DOPAMINEBETAHYDROXYLASE and phenylethanolamine-N-methyltransferase in discrete brain regions of the copper-zinc deficient rat following …
  214. Menstrual cycle and ovarian hormone effects on plasma and platelet monoamine oxidase (MAO) and plasma DOPAMINEBETAHYDROXYLASE (DBH) activities in the …
  215. Plasma DOPAMINEBETAHYDROXYLASE (DBH) activity during the menstrual cycle
  216. DOPAMINEBETAHYDROXYLASE and its apparent endogenous inhibitory activity in the plasma of some psychiatric patients
  217. Glycosylation and membrane insertion of newly synthesized rat DOPAMINE BETAHYDROXYLASE in a cell-free system without signal cleavage.
  218. Catecholamine metabolites affected by the copper-dependent enzyme DOPAMINEBETAHYDROXYLASE provide sensitive biomarkers for early diagnosis of menkes …
  219. Effect of DOPAMINEBETAHYDROXYLASE inhibition on cerebral vasospasm in the cat
  220. Serum DOPAMINE BETAHYDROXYLASE activity following subarachnoid hemorrhage in man.
  221. Highly effective mechanism-based inactivation of DOPAMINE. BETA.-HYDROXYLASE by a novel ketene thioacetal
  222. Active site labeling of DOPAMINE BETAHYDROXYLASE by two mechanism-based inhibitors: 6-hydroxybenzofuran and phenylhydrazine.
  223. Plasma renin and serum DOPAMINEBETAHYDROXYLASE during orthostatic hypotension in quadriplegic man.
  224. Purification and properties of human serum DOPAMINEBETAHYDROXYLASE .
  225. Levels of DOPAMINE BETA HYDROXYLASE immunoreactivity in the preoptic hypothalamus of the ovariectomised ewe following injection of oestrogen: evidence for …
  226. Association of DOPAMINE BETAHYDROXYLASE (DBH) polymorphisms with susceptibility to Parkinson’s disease
  227. Nerve fibers immunoreactive to calcitonin gene-related peptide, substance P, neuropeptide Y, and DOPAMINE BETAHYDROXYLASE in innervated and denervated oral …
  228. The relationship between serotonin, DOPAMINE BETA HYDROXYLASE and GABA immunoreactive inputs and spinal preganglionic neurones projecting to the major pelvic …
  229. Heart rate variation and serum DOPAMINEBETAHYDROXYLASE activity in workers exposed to vibration
  230. Proportions of renal and splenic postganglionic sympathetic populations containing galanin and DOPAMINE BETA HYDROXYLASE
  231. Synthesis of chromogranins and DOPAMINE BETAHYDROXYLASE by perfused bovine adrenal glands.
  232. Hypertensive crises in quadriplegic patients. Changes in cardiac output, blood volume, serum DOPAMINEBETAHYDROXYLASE activity, and arterial prostaglandin PGE2.
  233. Brain DOPAMINE BETA HYDROXYLASE activity: response to stress, tyrosine HYDROXYLASE inhibition, hypophysectomy and ACTH administration
  234. The in situ kinetics of DOPAMINE BETAHYDROXYLASE in bovine adrenomedullary chromaffin cells. Intravesicular compartmentation reduces apparent affinity for the …
  235. Human plasma DOPAMINEBETAHYDROXYLASE : variation in thermal stability
  236. The molecular shape of DOPAMINE BETAHYDROXYLASE from chromaffin granules of bovine adrenal medulla.
  237. Purification and characterization of avian DOPAMINE. BETA.-HYDROXYLASE
  238. The association of C789A polymorphism in the DOPAMINE BETAHYDROXYLASE gene (DBH) and aggressive behaviour in dogs
  239. Serum DOPAMINEBETAHYDROXYLASE in depressed patients and the effect of electroconvulsive shock treatment
  240. A genetic study of plasma DOPAMINE BETAHYDROXYLASE in affective disorder.
  241. DOPAMINE BETA HYDROXYLASE : an enzyme with therapeutic potential to combat neural and cardiovascular diseases
  242. Sensation seeking, exercise, and DOPAMINE BETA HYDROXYLASE
  243. Changes in platelet monoamine oxidase and plasma DOPAMINEBETAHYDROXYLASE activities in lithium-treated bipolar patients
  244. Inactivation of DOPAMINE. BETA.-HYDROXYLASE by. BETA.-ethynyltyramine: kinetic characterization and covalent modification of an active site peptide
  245. Mechanism-based inhibitors of DOPAMINE. BETA.-HYDROXYLASE : inhibition by 2-bromo-3-(p-hydroxyphenyl)-1-propene
  246. Release of norepinephrine and DOPAMINEBETAHYDROXYLASE by nerve stimulation. V. Enhanced release associated with a granular effect of a benzoquinolizine …
  247. Alternate substrates of DOPAMINE BETAHYDROXYLASE . III. Stoichiometry of the inactivation reaction with benzyl cyanides and spectroscopic investigations.
  248. Association Between DOPAMINE BETAHYDROXYLASE Gene Polymorphisms and Attention-Deficit Hyperactivity Disorder in Korean Children
  249. Effect of variations in adrenocortical function on DOPAMINE BETAHYDROXYLASE and norepinephrine in the brain of the rat.
  250. Role of copper and catalytic mechanism in the copper monooxygenase, DOPAMINE BETAHYDROXYLASE (D BETA H).
  251. Distribution of DOPAMINE BETAHYDROXYLASE and neuropeptide Y-immunoreactive nerves in healthy equine lungs.
  252. Distribution of DOPAMINEBETAHYDROXYLASE —like immunoreactivity in the rat pineal organ
  253. A single nucleotide polymorphism in DOPAMINE BETA HYDROXYLASE (rs6271 (C> T)) is over-represented in inflammatory bowel disease patients and reduces …
  254. Variants of DOPAMINE BETA HYDROXYLASE gene moderate atomoxetine response in children with attention-deficit/hyperactivity disorder
  255. Association of functional DOPAMINEBETAHYDROXYLASE (DBH) 19 bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers
  256. Bovine membranous DOPAMINE BETAHYDROXYLASE is not anchored via covalently attached phosphatidylinositol.
  257. DOPAMINE BETAHYDROXYLASE activity in the cat carotid body
  258. Anti-hypertensive effect of acebutolol: its relation to sympathetic nervous system responsiveness and to plasma renin and DOPAMINEBETAHYDROXYLASE activities.
  259. Pharmacological action of FD-008, a new DOPAMINEBETAHYDROXYLASE inhibitor.
  260. Adenosine 5′-diphosphate-dependent subunit dissociation of bovine DOPAMINE BETAHYDROXYLASE .
  261. Association between DOPAMINE BETA HYDROXYLASE gene polymorphism and age at onset in male schizophrenia
  262. The influence of DOPAMINEBETAHYDROXYLASE and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with …
  263. Generation of two noradrenergic-specific DOPAMINEBETAHYDROXYLASE -FLPo knock-in mice using CRISPR/Cas9-Mediated targeting in embryonic stem cells
  264. Some characteristics of amnesia induced by FLA-63 an inhibitor of DOPAMINE BETA HYDROXYLASE
  265. Effects of various inhibitors of tyrosine HYDROXYLASE and DOPAMINE BETAHYDROXYLASE on rat self-stimulation after reserpine treatment
  266. Effects of aging on the activity of hypothalamic DOPAMINEBETAHYDROXYLASE during various stages of the estrous cycle in C57BL/6 mice
  267. Relationship to survival of catecholamine levels and DOPAMINEBETAHYDROXYLASE activity in experimental haemorrhagic shock.
  268. Circulating catecholamines, plasma renin and DOPAMINEBETAHYDROXYLASE activity with postural stress
  269. Serum DOPAMINEBETAHYDROXYLASE activity in women occupationally exposed to carbon disulphide
  270. Serum DOPAMINEBETAHYDROXYLASE in diagnostic subgroups of depressed patients and in relation to their personality characteristics
  271. Serum DOPAMINE BETAHYDROXYLASE activity in essential hypertension.
  272. Alternate substrates of DOPAMINE BETAHYDROXYLASE . II. Inhibition by benzyl cyanides and reactivation of inhibited enzyme.
  273. Influence of age, sex and hypoxia on plasma DOPAMINEBETAHYDROXYLASE activity in the rat.
  274. Concentration of DOPAMINE in plasma, activity of DOPAMINE BETAHYDROXYLASE in serum and urinary excretion of free catecholamines and vanillylmandelic acid in …
  275. Immunocytochemical colocalizations of insulin, aromatic L-amino acid decarboxylase, DOPAMINE BETAHYDROXYLASE , S-100 protein and chromogranin A in B-cells of the …
  276. The study of levels of norepinephrine and DOPAMINEBETAHYDROXYLASE in patients with pregnancy-induced hypertension.
  277. Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in DOPAMINEBETAHYDROXYLASE deficiency.
  278. DOPAMINEBETAHYDROXYLASE after treatment with BETA-blockers in hypertension.
  279. Effect of monensin on synthesis, post-translational processing, and secretion of DOPAMINE BETAHYDROXYLASE from PC12 pheochromocytoma cells.
  280. Plasma catecholamines and DOPAMINEBETAHYDROXYLASE activity in chronic renal failure
  281. Serum DOPAMINE BETA HYDROXYLASE activity and tardive dyskinesia
  282. … mesenteric ganglion. A. Changes in expression of transmitter-synthesizing enzymes–tyrosine HYDROXYLASE , DOPAMINE BETAHYDROXYLASE and choline acetyltransferase …
  283. Linkage analysis between manic depressive illness and the DOPAMINE BETAHYDROXYLASE gene.
  284. Deglycosylated membranous and soluble DOPAMINE BETAHYDROXYLASE have identical apparent molecular weights
  285. Linkage studies of catechol-O-methyltransferase (COMT) and DOPAMINEBETAHYDROXYLASE (DBH) cDNA expression levels
  286. Adrenal origin of the increase in plasma DOPAMINE BETAHYDROXYLASE and catecholamines induced by hemorrhagic hypotension in dogs.
  287. Normal values for serum DOPAMINEBETAHYDROXYLASE activity.
  288. Immunohistochemical colocalization of insulin, aromatic L-amino acid decarboxylase and DOPAMINE BETAHYDROXYLASE in islet B cells of chicken pancreas
  289. Serum DOPAMINEBETAHYDROXYLASE (DBH) activity and blood pressure response of rat strains to shock-induced fighting
  290. Screening of Inhibitory Activity of Edible Mushrooms on DOPAMINE
  291. Adrenal and hypothalamic DOPAMINEBETAHYDROXYLASE activity in the hamster: Evidence for species‐distinctive day‐night and post‐pinealectomy differences in …
  292. Effect of linoleic acid-rich diet on blood pressure, lipids, catecholamines, and DOPAMINEBETAHYDROXYLASE in spontaneously hypertensive rats.
  293. DOPAMINE BETAHYDROXYLASE inhibition reveals a selective influence of endotoxin on catecholamine content of rat tissues.
  294. Cerebrospinal fluid and plasma DOPAMINEBETAHYDROXYLASE activity in human hypertension.
  295. Membrane DOPAMINE BETAHYDROXYLASE : a precursor for the soluble enzyme in the bovine adrenal medulla.
  296. DOPAMINE BETAHYDROXYLASE and plasma renin activity in patients with low-, normal-, and high-renin essential hypertension.
  297. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma DOPAMINEBETAHYDROXYLASE .
  298. DOPAMINEBETAHYDROXYLASE : a modulator of BETA adrenergic receptor activity.
  299. Urinary catecholamine excretion and plasma DOPAMINEBETAHYDROXYLASE activity during mental work performed in some periods of menstrual cycle in women.
  300. Sequence tagged site (STS) TaqI RFLP at DOPAMINE BETAHYDROXYLASE (DBH).
  301. Serum DOPAMINEBETAHYDROXYLASE activity in depression and anxiety.
  302. Effect of atropine and acetylcholine on nerve stimulated output of noradrenaline and DOPAMINEBETAHYDROXYLASE from isolated rabbit and guinea pig hearts
  303. Changes in tyrosine HYDROXYLASE and DOPAMINEBETAHYDROXYLASE activities but not in phenylethanolamine-N-methyltransferase activity within central adrenaline …
  304. Effects of insulin-like growth factor-1 (IGF-1) receptor signaling on rates of apoptosis in retina of DOPAMINE BETA HYDROXYLASE (Dbh−/−) knockout mice
  305. … performance in elderly women: significance of the 19bp insertion/deletion polymorphism in the 5′ flank of the DOPAMINE BETAHYDROXYLASE gene, educational level …
  306. Effect of DOPAMINEBETAHYDROXYLASE inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
  307. DOPAMINE BETAHYDROXYLASE in human synovial fluid
  308. Effects of transgenic expression of DOPAMINE BETA HYDROXYLASE (Dbh) gene on blood pressure in spontaneously hypertensive rats
  309. Serum DOPAMINE BETA HYDROXYLASE activity and metoclopramide provocative test in torsion dystonia
  310. Kinetic studies with competitive inhibitors indicate a sequential mechanism for DOPAMINE BETAHYDROXYLASE .
  311. Plasma DOPAMINEBETAHYDROXYLASE activity and catecholamine levels in anesthetized dogs following acute hemorrhage
  312. Effects of the novel DOPAMINE BETAHYDROXYLASE inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
  313. … and DOPAMINEBETAHYDROXYLASE induced by forced immobilization and insulin-induced hypoglycemia: origin and fate of plasma DOPAMINEBETAHYDROXYLASE .
  314. Contribution of adrenal medulla, spleen and lymph, to the plasma levels of DOPAMINE BETAHYDROXYLASE and catecholamines induced by hemorrhagic …
  315. Plasma and lymph DOPAMINEBETAHYDROXYLASE and norepinephrine during carotid occlusion
  316. … of substituted DL-3 (5-benzazolyl) alanines as dopa and alpha-methyldopa analogs and their effects on DOPAMINE BETAHYDROXYLASE , tyrosinase and diphenoloxidase.
  317. Immunofluorescent patterns of clathrin and DOPAMINE BETAHYDROXYLASE in chromaffin cells in culture
  318. Plasma DOPAMINEBETAHYDROXYLASE activity in depressed patients: role of treatment.
  319. Evidence for inhibition of DOPAMINEBETAHYDROXYLASE in vivo after sub-acute pyrazole treatment in rats.
  320. The effects of therapy for mild hypertension on circulating level of DOPAMINE BETAHYDROXYLASE
  321. Circulating DOPAMINEBETAHYDROXYLASE (DBETAH) and catecholamines in a paediatric phaeochromocytoma.
  322. DOPAMINE BETAHYDROXYLASE gene excluded in four subtypes of hereditary dystonia
  323. Co-expression of tyrosine HYDROXYLASE , DOPAMINE BETAHYDROXYLASE and neuropeptide Y in the sympathetic neurons projecting to the submandibular gland in the …
  324. Long-term effects of propranolol on tyrosine HYDROXYLASE and DOPAMINEBETAHYDROXYLASE in the superior cervical ganglia of the rabbit [proceedings].
  325. Platelet monoamine oxidase and plasma DOPAMINEBETAHYDROXYLASE activities in patients with multiple sclerosis
  326. Electroacupuncture analgesia is improved by adenoviral gene transfer of DOPAMINE BETAHYDROXYLASE into the hypothalamus of rats
  327. Anion-and pH-dependent activation of the soluble form of DOPAMINE BETAHYDROXYLASE
  328. DOPAMINE BETAHYDROXYLASE inhibition: A potential therapy for the treatment of congestive heart failure
  329. Circulating pool and adrenal soluble content of DOPAMINE BETAHYDROXYLASE (DBH), in rats, guinea pigs, dogs and humans: their role in determining acute stress …
  330. Immunocytochemical demonstration of DOPAMINEBETAHYDROXYLASE and cytochrome B561 on the axonal reticulum in bovine sympathetic neurons.
  331. Synthesis of chromogranin A, DOPAMINE BETAHYDROXYLASE , and chromaffin vesicles
  332. Evidence that DOPAMINEBETAHYDROXYLASE immunoreactive neurons in the lateral reticular nucleus project to the spinal cord in the rat
  333. d, l-threo-3, 4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in DOPAMINE BETAHYDROXYLASE deficiency
  334. Interactions of amphetamine, pimozide, and lithium on plasma norepinephrine and DOPAMINEBETAHYDROXYLASE in schizophrenic patients
  335. Prenatal reserpine administration: permanent changes in adrenal tyrosine HYDROXYLASE and DOPAMINE BETAHYDROXYLASE .
  336. Subunit characterization and primary structure of bovine adrenal medullary DOPAMINE BETAHYDROXYLASE .
  337. Mechanism of inhibition of DOPAMINE BETAHYDROXYLASE evoked by FLA-63. An in vitro study.
  338. Plasma DOPAMINEBETAHYDROXYLASE and erythrocyte acetylcholinesterase in a group of patients with Parkinson disease
  339. Effect of electroconvulsive treatment on serum DOPAMINEBETAHYDROXYLASE activity in man
  340. Central and peripheral DOPAMINE BETA HYDROXYLASE : responses to long term treatment with monoamine oxidase inhibitors
  341. Peripartum management of a patient with DOPAMINE BETAHYDROXYLASE deficiency, a rare congenital cause of dysautonomia
  342. 1-(Substituted-benzyl) imidazole-2 (3H) thione inhibitors of DOPAMINE. BETA.-HYDROXYLASE
  343. Association between DOPAMINE BETAHYDROXYLASE polymorphism and attention function in suicide attempters with chronic schizophrenia
  344. Circulating DOPAMINEBETAHYDROXYLASE in the rat: importance of altered disposal pathways in experimental diabetes.
  345. In vitro effect of dithiocarbamate pesticides and of CaNa2EDTA on human serum DOPAMINEBETAHYDROXYLASE .
  346. Effect of chronically administered nicotine on axonal transport of DOPAMINEBETAHYDROXYLASE in peripheral adrenergic neurons and on blood pressure and heart rate …
  347. Fumarate is the cause of the apparent ping-pong kinetics of DOPAMINE BETAHYDROXYLASE .
  348. DOPAMINE BETA HYDROXYLASE : its relevance in the etiology of attention deficit hyperactivity disorder
  349. Inhibition by cyclopropane of release od norepinephrine, but not DOPAMINEBETAHYDROXYLASE , from the guinea-pig vas deferens.
  350. The effect of alpha, alpha1-dipyridyl on noradrenaline, DOPAMINE and 5-hydroxytryptamine levels and on DOPAMINEBETAHYDROXYLASE activity in brain.
  351. … excess and/or norepinephrine and epinephrine deficiency in autistic patients due to prenatal and/or postnatal deficiency of DOPAMINE BETAHYDROXYLASE
  352. Serum DOPAMINEBETAHYDROXYLASE in manic-depressive psychosis
  353. Sleeping with and without norepinephrine: effects of metoclopramide and D, L-threo-3, 4-dihydroxyphenylserine on sleep in DOPAMINE BETAHYDROXYLASE deficiency
  354. RNAi-mediated knock-down of the DOPAMINE BETAHYDROXYLASE gene changes growth of razor clams
  355. Lack of correlation between serum DOPAMINEBETAHYDROXYLASE activity and blood pressure in middle-aged men.
  356. Immunofluorescent and biochemical studies on DOPAMINEBETAHYDROXYLASE and catecholamines in SIF cells of the superior cervical ganglion.
  357. Changes in human plasma catecholamines and DOPAMINEBETAHYDROXYLASE produced by prostaglandin F2α
  358. Immunological localization of DOPAMINEBETAHYDROXYLASE on the chromaffin granule membrane
  359. Neuroleptic drug effect on plasma DOPAMINEBETAHYDROXYLASE in schizophrenia
  360. A linkage study of affective disorder with DNA markers for the ABO-AK1-ORM linkage group near the DOPAMINE BETA HYDROXYLASE gene
  361. DOPAMINEBETAHYDROXYLASE activity in the axillary bodies, the heart and the splanchnic nerve in two elasmobranchs, Squalus acanthias and Etmopterus spinax.
  362. Studies on the interaction of DOPAMINE BETAHYDROXYLASE from various sources with phytohaemagglutinins.
  363. Changes in adrenal DOPAMINE concentration after metyrapone or acth administration: Implications for the in vivo regulation of DOPAMINE BETAHYDROXYLASE by …
  364. L–arginine alleviates postmenopausal complications in female rats by stimulating ovarian DOPAMINE BETA HYDROXYLASE
  365. Adrenergic storage vesicles in rat heart: quantitation of membrane-bound and membrane-enclosed DOPAMINE BETAHYDROXYLASE .
  366. Changes in the expression of tyrosine HYDROXYLASE (TH), DOPAMINE BETAHYDROXYLASE (DBH), galanin (GAL), vasoactive intestinal polypeptide (VIP) and substance P …
  367. Epinephrine and DOPAMINE BETAHYDROXYLASE secretion from bovine adrenal.
  368. Serum DOPAMINE BETAHYDROXYLASE activity in acute cardiac disease
  369. 1-(Thienylalkyl) imidazole-2 (3H)-thiones as potent competitive inhibitors of DOPAMINE. BETA.-HYDROXYLASE
  370. Endoglycosidase H susceptibility of secreted and intracellular forms of DOPAMINE BETAHYDROXYLASE .
  371. Evolution of plasma DOPAMINEBETAHYDROXYLASE in hypo-and hyperthyroid young rats
  372. Segregation analysis of DOPAMINEBETAHYDROXYLASE (DBH) and catechol‐o‐methyltransferase (COMT): Identification of major locus and polygenic components
  373. Modification of cerebrovascular CO2 reactivity by inhibition of DOPAMINE BETAHYDROXYLASE .
  374. Immunofluorescence of DOPAMINEBETAHYDROXYLASE in small intensely fluorescent cells of human sympathetic ganglia
  375. Retrograde axonal transport of DOPAMINE BETA HYDROXYLASE antibodies by neurons in the trigeminal ganglion
  376. Substituted picolinic acids as DBH inhibitors. Inhibition of DOPAMINE BETAHYDROXYLASE and antihypertensive action
  377. Genetic loss of norepinephrine does not alter adult hippocampal neurogenesis in DOPAMINE BETAHYDROXYLASE deficient mice
  378. RFLP for human DBH (DOPAMINE BETAHYDROXYLASE )
  379. … of bovine chromaffin granules in isotonic solutions of salts of weak organic acids. Release of catecholamines, ATP, DOPAMINE BETAHYDROXYLASE , and enkephalin-like …
  380. Nerve fibers showing immunoreactivities for thyrosine HYDROXYLASE and DOPAMINEBETAHYDROXYLASE re‐appear in the guinea pig uvea after sympathectomy
  381. Plasma DOPAMINE BETA HYDROXYLASE (DBH) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading
  382. Changes in serum DOPAMINEBETAHYDROXYLASE activity during cold pressor test in subjects with high and low basal activity of this enzyme
  383. Lack of association between DOPAMINE BETAHYDROXYLASE (dbh) 19-bp insertion/deletion polymorphism and risk of schizophrenia
  384. Cholinergic and GABAergic regulation of DOPAMINE BETAHYDROXYLASE activity in the adrenal gland of the rat.
  385. Plasma and tumor DOPAMINEBETAHYDROXYLASE activity in patients with familial pheochromocytomas
  386. Plasma DOPAMINEBETAHYDROXYLASE activity and thyroid suppressibility in Graves’ disease
  387. A family study of plasma DOPAMINEBETAHYDROXYLASE in schizophrenia
  388. Inhibition of DOPAMINE BETAHYDROXYLASE by 4-hydroxypyrazole: ethanol-pyrazole effects on serum DOPAMINE BETAHYDROXYLASE in vivo.
  389. Circadian changes in adrenal DOPAMINEBETAHYDROXYLASE activity: dependency of change at darkness onset, and the effect of pinealectomy, on animal strain and age.
  390. An Electron Microscopic Immunocytochemical Study on the Tyrosine HYDROXYLASE ‐Positive, DOPAMINE BETAHYDROXYLASE ‐Negative Cells in the Pineal Gland of …
  391. Molecular forms of DOPAMINE BETAHYDROXYLASE in rat superior cervical ganglion and adrenal gland
  392. Changes in plasma DOPAMINE BETAHYDROXYLASE activity induced by stimulation of the complete sympathetic outflow in the pithed rat.
  393. The influence of DOPAMINEBETAHYDROXYLASE inhibitors on avoidance reaction in rat.
  394. Effects of prolonged disulfiram treatment on plasma DOPAMINEBETAHYDROXYLASE activity in rhesus monkeys.
  395. Noradrenaline and DOPAMINEBETAHYDROXYLASE levels in rat salivary glands after preganglionic nerve stimulation: Evidence for re-use of amine storage granules in …
  396. Alterations in plasma DOPAMINEBETAHYDROXYLASE and catecholamine concentrations during surgical removal of pheochromocytoma.
  397. Development of DOPAMINEBETAHYDROXYLASE —positive fiber innervation in co‐cultured hippocampus‐locus coeruleus organotypic slices
  398. Lithium: effects of short-term and chronic treatments in rats on the activity of DOPAMINEBETAHYDROXYLASE (DBH) in the central versus peripheral nervous system
  399. Synthesis of several 2-substituted 3-(p-hydroxyphenyl)-1-propenes and their characterization as mechanism-based inhibitors of DOPAMINE BETAHYDROXYLASE .
  400. Mechanism-based inhibition of DOPAMINE-. BETA.-HYDROXYLASE
  401. From gene to disease; DOPAMINEBETAHYDROXYLASE deficiency and orthostatic hypotension
  402. Congenital DOPAMINE BETAHYDROXYLASE deficiency
  403. Cerebrospinal fluid norepinephrine and DOPAMINEBETAHYDROXYLASE in affective illness and schizophrenia
  404. Serum DOPAMINEBETAHYDROXYLASE activity in a new strain of spontaneously hypertensive rats
  405. Mechanistic and Structural Studies of DOPAMINE BETAHYDROXYLASE
  406. Effects of short-term lithium treatment in rats on the activity of DOPAMINEBETAHYDROXYLASE in various brain regions.
  407. DOPAMINEBETAHYDROXYLASE activity in serum of patients with hepatic damage.
  408. Construction of Nursing Intervention Model and Clinical Empirical Study on DOPAMINE BETA HYDROXYLASE Gene Polymorphism in Children with ADHD
  409. Benzofurans as mechanism-based inhibitors of DOPAMINE. BETA.-HYDROXYLASE
  410. Effects of phenyl-2-aminoethyl sulfide, a novel DOPAMINEBETAHYDROXYLASE substrate, on the cardiovascular system of the anesthetized dog.
  411. Effect of BETA-adrenergic blockade on plasma DOPAMINEBETAHYDROXYLASE activity and triiodothyronine in hyperthyroidism
  412. Measurements of noradrenaline overflow and DOPAMINEBETAHYDROXYLASE activity in superfused preparations [proceedings]
  413. Catecholamine‐containing, DOPAMINEBETAHYDROXYLASE ‐immunoreactive perivascular nerve specializations in the rat kidney
  414. Changes in serum DOPAMINE BETA HYDROXYLASE activity related to coma.
  415. Pharmacological action of FD-008, a new DOPAMINEBETAHYDROXYLASE inhibitor. III. Effects on endogenous biogenic amine levels in rats.
  416. DOPAMINEBETAHYDROXYLASE (DBH) AND PUPILLARY SYMPATHETIC ACTIVITY IN IDIOPATHIC TORSION DYSTONIA (ITD)
  417. Plasma noradrenalin and DOPAMINEBETAHYDROXYLASE during behavioral testing of sexually deviant XYY and XXY males
  418. Relationship between DOPAMINEBETAHYDROXYLASE gene polymorphism and hypertensive disorder complicating pregnancy
  419. Synthesis of 6-alkylaminopyridazine-3-carboxylic acid derivatives as DOPAMINE BETAHYDROXYLASE inhibitors
  420. Metabolic clearance rate of DOPAMINE BETAHYDROXYLASE in the rat.
  421. DOPAMINEBETAHYDROXYLASE activity in adrenal gland and spleen of rats after fasting and cold exposure
  422. Modification of plasma DOPAMINEBETAHYDROXYLASE activity by adrenal and pineal extirpations, and time of day dependency of changes.
  423. DOPAMINE BETAHYDROXYLASE activity in cerebrospinal fluid of idiopathic torsion dystonia
  424. Effect of butobendin on DOPAMINE BETAHYDROXYLASE in vitro.
  425. DOPAMINE BETA HYDROXYLASE . Value and limits of its study in neurology
  426. Effect of DOPAMINEBETAHYDROXYLASE inhibitor (disulfiram) on the response of adenohypophysis, serum ceruloplasmin and hypothalamic ascorbic acid to estradiol …
  427. DOPAMINEBETAHYDROXYLASE effectors in neuroblastoma
  428. Comparison of physico-chemical properties of two forms of DOPAMINEBETAHYDROXYLASE from chromaffin granules
  429. Proceedings: The mechanism of the effect of DOPAMINEBETAHYDROXYLASE inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
  430. Responses of plasma renin activity and DOPAMINEBETAHYDROXYLASE to increased intravascular volume
  431. Low serum DOPAMINEBETAHYDROXYLASE activity in patients with panic disorder
  432. Antiarrhythmic efficiency of Craviten and changes in the activities of serum DOPAMINE BETAHYDROXYLASE and erythrocyte membrane ATPases.
  433. DOPAMINEBETAHYDROXYLASE activity after acute myocardial infarction.
  434. Control of Synthesis, Transport and Release of DOPAMINEBETAHYDROXYLASE and Tyrosine HYDROXYLASE
  435. DOPAMINE BETAHYDROXYLASE activity in cerebrospinal fluid of hydrocephalic patients
  436. Plasma DOPAMINEBETAHYDROXYLASE activity in spasmodic torticollis
  437. Serum DOPAMINEBETAHYDROXYLASE activity in fasting man.
  438. Anion activation of DOPAMINE BETAHYDROXYLASE : a kinetic model.
  439. Structural and kinetic studies of bovine DOPAMINE BETAHYDROXYLASE
  440. Plasma DOPAMINEBETAHYDROXYLASE in neuroblastoma.
  441. Effects of Herbal Drugs on Bovine Adrenal Tyrosine HYDROXYLASE and DOPAMINE (II)
  442. Structural study of DOPAMINE BETA HYDROXYLASE purified from human serum
  443. Biosynthesis, glycosylation and cellular sorting of human DOPAMINE BETAHYDROXYLASE .
  444. Plasma catecholamine concentration and DOPAMINEBETAHYDROXYLASE activity during haemodialysis with acetate or bicarbonate at different sodium concentrations in …
  445. Developmental pattern of DOPAMINE BETAHYDROXYLASE induction in the adrenals of the rat. Influence of neonatal hypothyroidism.
  446. Studies on the stability of an enzyme-inhibitor complex using a mechanism-based inhibitor of DOPAMINE. BETA.-HYDROXYLASE
  447. Sympathoadrenal activity and plasma glucose effects on plasma DOPAMINEBETAHYDROXYLASE levels in rats
  448. Lymphocyte BETA-adrenoreceptor function in congestive heart failure: modulation by DOPAMINEBETAHYDROXYLASE
  449. Interaction of central neurotransmitters in the regulation of adrenal DOPAMINE BETAHYDROXYLASE
  450. Changes in plasma DOPAMINEBETAHYDROXYLASE activity in patients with acute subarachnoid hemorrhage (author’s transl)
  451. Preparations of human DOPAMINE BETA HYDROXYLASE subunits and antibodies against these subunits (author’s transl)
  452. Using plasma DOPAMINE BETAHYDROXYLASE activity and its interrelations with bioelement content to predict depression in the rat model
  453. Clinical and Functional Implications of the Arg549Cys (rs6271) Polymorphism in DOPAMINE BETAHYDROXYLASE
  454. Brain DOPAMINE BETA HYDROXYLASE Activity In Vivo: Pharmacological, Endocrinological, and Psychological Implications for Adaptation
  455. Regulation of the translation and processing of rat DOPAMINE BETAHYDROXYLASE by metal ions in a cell free system.
  456. DOPAMINE BETAHYDROXYLASE
  457. Plasma DOPAMINE BETA HYDROXYLASE activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel).
  458. Implication of cerebral DOPAMINEBETA HYDROXYLASE for cardiovascular and mood regulation in rats
  459. The stimulated release of DOPAMINEBETAHYDROXYLASE from intact organs of normo-and hypertensive rats [proceedings].
  460. Co-expression pattern of DOPAMINE BETAHYDROXYLASE (DβH) and neuropeptide Y (NPY) within sympathetic innervation of ovary and umbilical cord of the European …
  461. DOPAMINEBETAHYDROXYLASE activity in plasma, spleen and adrenal gland of streptozotocin-diabetic rats: correlation with cataracts.
  462. DYNAMICS OF PLASMA AND LYMPH DOPAMINEBETAHYDROXYLASE AS RELATED TO SYMPATHETIC NERVOUS SYSTEM ACTIVITY.
  463. Serum DOPAMINE BETA HYDROXYLASE (DβH) enzyme activity changes within individual women according to stage of pregnancy: Evidence that regulation of expression …
  464. The effects of some DOPAMINEBETAHYDROXYLASE inhibitors on the control mechanisms of the estrous cycle in rats.
  465. Alteration of blood DOPAMINEBETAHYDROXYLASE activity in patients with intrahepatic portal hypertension
  466. An Association Study between Four Polymorphisms in the DOPAMINE BETAHYDROXYLASE Gene and Schizophrenia in Korean Population
  467. Catecholamines and the DOPAMINEBETAHYDROXYLASE activity of the blood plasma in motor pathology in children: the role of central and peripheral mechanisms
  468. Activity of plasma DOPAMINEBETAHYDROXYLASE and urine excretion of catecholamines in patients with deficiency-cold and deficiency-heat syndromes
  469. The 444G/A and-1021 C/T polymorphisms of the DOPAMINEBETAHYDROXYLASE gene modulate the trajectory of alcohol dependence development
  470. A family-based and case-control association study of the DOPAMINE BETA HYDROXYLASE gene polymorphism in attention deficit hyperactivity disorder
  471. DOPAMINEBETAHYDROXYLASE inhibitors, feeding and locomotir activity: Reinstatement of feeding following central norepinephrine
  472. Effect of substance P on DOPAMINEBETAHYDROXYLASE and phenethanolamine-N-methyltransferase in the adrenal glands of rats
  473. The Role of the DOPAMINE BETAHYDROXYLASE Functional Polymorphism in Patients with Early-Onset Parkinson’s Disease in the Turkish Population
  474. Noradrenergic innervation of rat neocortex during development: immunocytochemical evidence using anti-DOPAMINEBETAHYDROXYLASE antibodies
  475. Ontogeny of epinephrine, norepinephrine, DOPAMINEBETAHYDROXYLASE , and chromogranin A in the adrenal gland of pigs.
  476. Proceedings: Effect of DOPAMINEBETAHYDROXYLASE inhibitors and centrally administered noradrenaline on (+)-amphetamine anorexia in mice.
  477. The activity of monoamine oxidase in the interscapular brown adipose tissue and DOPAMINEBETAHYDROXYLASE in the serum depends on the rat thyroid status
  478. Deglycosylation of DOPAMINE. BETA.-HYDROXYLASE
  479. Subclassification of hyperactive children on the basis of minor physical anomalies and plasma DOPAMINEBETAHYDROXYLASE activity: An attempted replication
  480. Asymmetrical content of DOPAMINEBETAHYDROXYLASE and phenylethanolamine-N-methyltransferase in the adrenals of spontaneously hypertensive and normotensive …
  481. Effects of DOPAMINE BETA HYDROXYLASE Levels in a Mouse Model of FD
  482. STRUCTURAL STUDIES OF DOPAMINE BETAHYDROXYLASE
  483. Hydrazines as inhibitors of DOPAMINE. BETA.-HYDROXYLASE
  484. Role of DOPAMINEBETAHYDROXYLASE in DOPAMINE metabolism in the heart
  485. MECHANISM-BASED INHIBITION OF DOPAMINE BETAHYDROXYLASE
  486. Kinetic properties of membrane DOPAMINEBETAHYDROXYLASE .
  487. … ) antidepressants? Despite the ability of the major metabolite of disulfiram (diethyldithiocarbamate) to inhibit the enzyme DOPAMINE BETAHYDROXYLASE and a report of …
  488. DOPAMINE BETAHYDROXYLASE activity after subarachnoid hemorrhage
  489. DOPAMINEBETAHYDROXYLASE in patients with cystic fibrosis
  490. Plasma DOPAMINEBETAHYDROXYLASE activity during labour in women.
  491. KINETIC STUDIES ON THE MECHANISMS OF TYROSINE HYDROXYLASE AND DOPAMINE BETAHYDROXYLASE
  492. DOPAMINE BETAHYDROXYLASE Deficiency GeneReview–Diagnosis: Additional Tests/Findings
  493. Ophthalmic Findings in Patients with DOPAMINE BETAHYDROXYLASE Deficiency
  494. STRUCTURAL ANALYSIS OF THE SOLUBLE FORM OF BOVINE DOPAMINE BETAHYDROXYLASE
  495. DOPAMINEBETAHYDROXYLASE : NOVEL SUBSTRATES, INHIBITORS AND MECHANISTIC STUDIES.
  496. Plasma DOPAMINE BETAHYDROXYLASE activity in clinically healthy children
  497. Screening of DOPAMINE inhibitory activity from various wild plants
  498. Biolchemical mechanism of the toxicity of dithiocarbamate series fungicides: The inhibitory action on DOPAMINE BETAHYDROXYLASE activity.
  499. … MONOSODIUM GLUTAMATE ON BRAIN TYROSINE HYDROXYLASE , DOPAMINEHYDROXYLASE , TRYPTOPHAN HYDROXYLASE AND MONOAMINE OXIDSE …
  500. The regulation of alpha-synuclein on tyrosine HYDROXYLASE or DOPAMINE BETA HYDROXYLASE
  501. ISOLATION AND STRUCTURAL COMPARISONS OF SOLUBLE AND MEMBRANE-BOUND DOPAMINEBETAHYDROXYLASE PROTEINS FROM HUMAN AND …
  502. Plasma DOPAMINEBETAHYDROXYLASE as an index of peripheral noradrenergic activity
  503. Etamicastat, a new DOPAMINE BETAHYDROXYLASE inhibitor: Pharmacological characterization
  504. Determination of DOPAMINEBETAHYDROXYLASE activity in human placenta at early stage
  505. PLASMA DOPAMINEBETAHYDROXYLASE ACTIVITY IN TOURETTE’S DISORDER AND CHRONIC MOTOR TIC DISORDER
  506. DOPAMINE BETAHYDROXYLASE and BETA 2-microglobulin in cerebrospinal fluid: early markers in Parkinson’s disease?
  507. A Study on Serum DOPAMINEHYDROXYLASE Activity and Thermostability in a Randomly Selected Population of Adults
  508. Correlation between the DOPAMINEBETAHYDROXYLASE activity and the level of plasma catecholamines during muscular exercise
  509. Effect of zamicastat, a DOPAMINE BETAHYDROXYLASE inhibitor, on the monocrotaline rat model of pulmonary arterial hypertension
  510. Plasma DOPAMINEBETAHYDROXYLASE (DBH) activity in two kinds of acute stress in rabbits.
  511. Determination of the adrenergic response by measurement of catecholamines and activity of DOPAMINEBETAHYDROXYLASE (D-BETA-B) in arterial capillary blood
  512. STRUCTURAL AND ENZYMATIC STUDIES OF DOPAMINEBETAHYDROXYLASE FROM BOVINE ADRENAL CHROMAFFIN GRANULES.
  513. Activity of plasma DOPAMINEBETAHYDROXYLASE in newborn infants. Implication in prematurity, maternal pathology and growth
  514. THE CORRELATION BETWEEN ONTOGENESIS OF PLASMA $ DOPAMINE-{BETA}-HYDROXYLASE $ ACTIVITY AND PSYCHOPATHOLOGY IN INFANTILE AUTISM
  515. Investigation of acquired hearing loss in DOPAMINE BETA HYDROXYLASE (DBH)-mutant mice
  516. Varied mechanisms of estradiol mediated regulation of DOPAMINE BETAHYDROXYLASE (DBH) gene transcription
  517. DOPAMINE BETAHYDROXYLASE activity and its interrelations with bioelements in serum of rats after electroconvulsive shock therapy
  518. Acupuncture Improves Withdrawal Symptoms by Inhibiting Tyrosine HYDROXYLASE and DOPAMINEBETAHYDROXYLASE Expression in the Midbrain of Heroin Re-addicted …
  519. CEREBROSPINAL FLUID NOREPINEPHRINE AND DOPAMINEBETAHYDROXYLASE IN AFFECTIVE ILLNESS AND SCHIZOPHRENIA
  520. Polymorphisms of the DOPAMINE BETAHYDROXYLASE (DBH) gene show associations with cognitive flexibility in mentally healthy adults
  521. Differences in the retrograde axonal transport of nerve growth factor and DOPAMINE BETAHYDROXYLASE
  522. Targeting of sympathetic neurons in vivo with an anti-DOPAMINE BETAHYDROXYLASE immunotoxin.
  523. Relationship Between Electroencephalographic (EEG) Synchronization and Plasma DOPAMINEBETAHYDROXYLASE (DBH) Activity in Patients
  524. The effect of one-time and repeated starvation on DOPAMINE BETAHYDROXYLASE serum activity in rats of various ages
  525. Pharmacological inhibition of DOPAMINE BETAHYDROXYLASE blocks cocaine‐induced reinstatement in rats
  526. Electron transfer to DOPAMINE BETAHYDROXYLASE in chromaffin granule membranes.
  527. Changes in human plasma DOPAMINEBETAHYDROXYLASE activity after ketamine and halothane anesthesia.
  528. Changes of DOPAMINEBETAHYDROXYLASE and activator protein-2 expression in spinal cord of formalin-induced rat pain model
  529. Synthesis of potential inhibitors of DOPAMINEBETAHYDROXYLASE : Heterocyclic analogues and sulfur-containing derivatives of BETA-phenethylamines
  530. An Epidemiological Study of the Relationship between Serum DOPAMINEBETAHYDROXYLASE Activity and Urinary Noradrenaline, and Their Relationship to Blood …
  531. Platelet mono amine oxidase and plasma DOPAMINE BETA HYDROXYLASE activity in patients with Schizophrenia
  532. Synthesis of carbon‐14 and tritium labeled DOPAMINE BETAHYDROXYLASE inhibitors of the imidazolinethione type
  533. Changes of DOPAMINEBETAHYDROXYLASE and activator protein-2? expression in spinal cord of formalin-induced rat pain model
  534. Screening of Vegetables for Inhibition Activity on DOPAMINEHYDROXYLASE (DBH) and Monoamine oxidase (MAO)
  535. Proceedings: Reduction of locomotor activity in mice by DOPAMINEBETAHYDROXYLASE inhibitors–evidence against the involvement of non-specific irritation.
  536. Regulatory mechanisms of DOPAMINE BETAHYDROXYLASE gene expression: Noradrenergic neuron-specific gene regulation
  537. Tyrosine HYDROXYLASE , DOPAMINEBETAHYDROXYLASE and Phenylethanolamine-N-Methyltransferase Immunoreactive Neurons of the Medulla Oblongata in the …
  538. Effects of DOPAMINE BETAHYDROXYLASE (DBH) inhibition on cocaine‐induced reinstatement in squirrel monkeys
  539. Synthesis of 5-(substituted alkyl) picolinic acids, the DOPAMINE. BETA.-HYDROXYLASE inhibitors. I.
  540. Distribution of DOPAMINEBETA HYDROXYLASE (DBH) immunoreactivity in male zebra finch brains: Effects of hormone and DSP-4 treatments
  541. Muscarinic regulation of the stimulated release of norepinephrine and DOPAMINEBETAHYDROXYLASE from sympathetic nerves to the heart.
  542. COMPARISONS OF PURIFIED DOPAMINEBETAHYDROXYLASE FROM BOVINE LARGE DENSE CORED NORADRENERGIC VESICLES AND …
  543. Genetics of autism: the maternal genotype at the DOPAMINE BETA HYDROXYLASE locus may be a factor in the etiology of autism and related pervasive developmental …
  544. Total Kininogen Levels, Plasma Renin Activity, DOPAMINEBETAHYDROXYLASE and Plasma Catecholamines in Chronic and Acute Renal Failure
  545. Alterations in DOPAMINE BETAHYDROXYLASE (DBH) activity, TAS (Total Antioxidative Status), Mg and Zn contents in human serum after Zn supplementation
  546. DOPAMINE BETAHYDROXYLASE : STRUCTURAL AND KINETIC STUDIES ON THE SOLUBLE AND MEMBRANOUS FORMS OF ENZYME FROM BOVINE …
  547. … T, Blazekovic A, Perkovic MN, Jercic KG, Sustar A, Smircic-Duvnjak L, Outeiro TF, Pivac N, Borovecki F. The influence of DOPAMINEBETAHYDROXYLASE and catechol O …
  548. … biological activity using an allogeneic intervertebral disc supplemented with transfected nucleus pulposus cells expressing exogenous DOPAMINE BETAHYDROXYLASE .
  549. Selective Ablation of DOPAMINE BETAHYDROXYLASE Neurons (Subpopulation of TH Neurons) in the Brain: New Insights into Brain Catecholaminergic Circuitry and …
  550. Comparative studies of urinary electrolyte excretion, the renin-angiotensin-aldosterone system and plasma DOPAMINEBETAHYDROXYLASE activity in patients with …
  551. … ADRENAL CHROMAFFIN GRANULE MEMBRANES FOLLOWING SECRETION (VESICLE, EXOCYTOSIS, CATECHOLAMINE, DOPAMINEBETAHYDROXYLASE
  552. Activity of the adrenergic nervous system in the pathophysiology of pregnancy and labor. I. DOPAMINE BETAHYDROXYLASE (DBH) activity in the plasma of women with …
  553. … monocytogenes and Mycobacterium tuberculosis-dendritic cells as an “Achilles’ Heel” and immune deficiency in DOPAMINE BETAHYDROXYLASE knock-out mice
  554. Syntheses and enzymatic studies of novel substrate analogs of phenylalanine HYDROXYLASE and DOPAMINE BETA monooxygenase
Shopping Cart
Scroll to Top